MAPT and Alzheimer disease: The finding that pTtau181 was the most sensitive marker of AD pathology is consistent with previous reports that plasma pTau-181, p-Tau-217, and p-Tau-231 may all be sensitive indicators of underlying AD pathology (22–26).